Skip to main content
. 2021 Mar 31;39(3):293–303. doi: 10.1002/hon.2864

TABLE 1.

Patients features

Patients features MCL FL
Analyzed tissue
BM 8/20 (40%) 23/23 (100%)
PB 12/20 (60%)
Median tumor infiltration by flow (range)
BM 42% (11%–78%) nd
PB 44% (0.03%–95%) nd
Clonal rearrangements  detected by PCR 15/20 (75%) 3/23 (13%)
“no marker patients” by PCR  5/20 (25%) 20/23 (100%)

Abbreviations: BM, bone marrow; FL, follicular lymphoma; MCL, mantle cell lymphoma; PB, peripheral blood.